ATRA Reiterates Support for Chapter 11 Bankruptcy Use to Address Mass Tort Litigation, Urges Meaningful Dialogue Amid Senate Judiciary Committee Hearing
Takeda Pharmaceutical Co. v. Painters Fund
(U.S., filed March 27, 2020): Urging the Court to review whether the chain of causation between a manufacturer’s allegedly false statements and end payments for prescription drugs is too attenuated to satisfy RICO’s proximate cause requirement. Also, to address whether everyone who pays for a product with an alleged latent risk or defect suffer injury sufficient to confer Article III standing.
The lack of oversight and transparency around third-party litigation funding threatens the integrity of our legal system
Together, let’s forge a legal landscape that makes equitable access to justice a living reality for all Georgians.
This is an opportunity to reassess the practices and regulations surrounding private-attorney contracting and to enact reforms that promote fairness, transparency and value for taxpayer dollars.
Allowing the company to continue the bankruptcy process will help ensure equitable and efficient resolution in complex mass tort claims